Oulu, Finland

Matti Kalervo Uhari

This inventor holds 2 USPTO granted patents. Top assignee: Leiras Oy. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matti Kalervo Uhari. Retrieved from https://idiyas.com/inventor/matti-kalervo-uhari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matti Kalervo Uhari

Introduction

Matti Kalervo Uhari is a notable inventor based in Oulu, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory infections. With a total of 2 patents to his name, Uhari's work has the potential to impact public health positively.

Latest Patents

Uhari's latest patents include innovative methods that utilize xylitol for treating respiratory infections. One of his key inventions is a method of treating acute otitis media in humans, which involves orally administering an effective amount of xylitol. This new use of xylitol showcases Uhari's commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Throughout his career, Uhari has been associated with Leiras Oy, a company known for its focus on pharmaceutical innovations. His work at Leiras Oy has allowed him to explore and develop new therapeutic methods that address common health issues.

Collaborations

Uhari has collaborated with Tero Tapani Kontiokari, a fellow professional in the field. Their partnership has likely contributed to the development of Uhari's innovative patents and research.

Conclusion

Matti Kalervo Uhari's contributions to the field of pharmaceuticals, particularly through his patents involving xylitol, highlight his role as an influential inventor. His work continues to pave the way for new treatments that can benefit many individuals suffering from respiratory infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…